These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8223894

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation.
    Suzuki M, Matsuda T, Asano S, Somboonthum P, Takuma K, Baba A.
    Br J Pharmacol; 1995 Jun; 115(4):703-11. PubMed ID: 7582494
    [Abstract] [Full Text] [Related]

  • 7. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB, Koek W.
    Eur J Pharmacol; 2000 Dec 08; 409(2):173-7. PubMed ID: 11104831
    [Abstract] [Full Text] [Related]

  • 8. In vivo characterization of the putative 5-HT1A receptor antagonist SDZ 216,525 using two models of somatodendritic 5-HT1A receptor function.
    Routledge C, Hartley J, Gurling J, Ashworth-Preece M, Brown G, Dourish CT.
    Neuropharmacology; 1994 Dec 08; 33(3-4):359-66. PubMed ID: 7984274
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190.
    Routledge C, Gurling J, Ashworth-Preece MA, Dourish CT.
    Eur J Pharmacol; 1995 Apr 04; 276(3):281-4. PubMed ID: 7601215
    [Abstract] [Full Text] [Related]

  • 10. 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors.
    Hajós-Korcsok E, Sharp T.
    Eur J Pharmacol; 1996 Oct 31; 314(3):285-91. PubMed ID: 8957248
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study.
    Hjorth S, Sharp T, Liu Y.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar 31; 341(3):149-57. PubMed ID: 1692973
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P, Lesourd M, Comoy E.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.